Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.84
+0.05 (0.30%)
At close: May 13, 2025, 4:00 PM
16.68
-0.16 (-0.95%)
Pre-market: May 14, 2025, 5:17 AM EDT
Pulse Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 119.28 | 118.04 | 44.37 | 61.14 | 28.61 | 12.46 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 8.01 | Upgrade
|
Cash & Short-Term Investments | 119.28 | 118.04 | 44.37 | 61.14 | 28.61 | 20.48 | Upgrade
|
Cash Growth | 241.92% | 166.06% | -27.44% | 113.67% | 39.75% | -19.38% | Upgrade
|
Receivables | - | - | - | - | 0.06 | - | Upgrade
|
Inventory | 0.03 | - | - | - | 5.82 | - | Upgrade
|
Prepaid Expenses | 1.6 | 1.41 | 0.96 | 1.01 | 2.13 | 1.86 | Upgrade
|
Total Current Assets | 120.91 | 119.45 | 45.33 | 62.15 | 36.63 | 22.34 | Upgrade
|
Property, Plant & Equipment | 7.95 | 8.32 | 8.78 | 10.02 | 11.25 | 11.92 | Upgrade
|
Goodwill | 2.79 | 2.79 | 2.79 | 2.79 | 2.79 | 2.79 | Upgrade
|
Other Intangible Assets | 1.05 | 1.22 | 1.89 | 2.55 | 3.22 | 3.88 | Upgrade
|
Other Long-Term Assets | 0.68 | 0.68 | 0.37 | 0.37 | 0.37 | 0.37 | Upgrade
|
Total Assets | 133.38 | 132.46 | 59.15 | 77.88 | 54.25 | 41.29 | Upgrade
|
Accounts Payable | 2.37 | 1.67 | 1.84 | 1.57 | 2.9 | 1.72 | Upgrade
|
Accrued Expenses | 3.98 | 5.83 | 3.81 | 2.55 | 3.78 | 3.76 | Upgrade
|
Short-Term Debt | - | - | - | - | 0.44 | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0.92 | - | - | Upgrade
|
Current Portion of Leases | 1.41 | 1.36 | 1.06 | 0.9 | 0.77 | 0.54 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 0.02 | - | Upgrade
|
Other Current Liabilities | - | 1.2 | - | 0.05 | 0.61 | 1.56 | Upgrade
|
Total Current Liabilities | 7.76 | 10.06 | 6.71 | 5.98 | 8.52 | 7.59 | Upgrade
|
Long-Term Debt | - | - | - | 65 | - | - | Upgrade
|
Long-Term Leases | 7.17 | 7.54 | 8.09 | 9.14 | 10.04 | 10.81 | Upgrade
|
Total Liabilities | 14.93 | 17.6 | 14.79 | 80.13 | 18.56 | 18.4 | Upgrade
|
Common Stock | 0.07 | 0.07 | 0.06 | 0.04 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 525.68 | 505.3 | 381.22 | 292.42 | 271.86 | 195.41 | Upgrade
|
Retained Earnings | -407.3 | -390.5 | -336.92 | -294.71 | -236.2 | -172.54 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | - | -0 | Upgrade
|
Shareholders' Equity | 118.45 | 114.86 | 44.36 | -2.25 | 35.69 | 22.89 | Upgrade
|
Total Liabilities & Equity | 133.38 | 132.46 | 59.15 | 77.88 | 54.25 | 41.29 | Upgrade
|
Total Debt | 8.58 | 8.9 | 9.14 | 75.96 | 11.25 | 11.36 | Upgrade
|
Net Cash (Debt) | 110.7 | 109.14 | 35.22 | -14.82 | 17.36 | 9.12 | Upgrade
|
Net Cash Growth | 325.97% | 209.87% | - | - | 90.42% | -51.18% | Upgrade
|
Net Cash Per Share | 1.82 | 1.87 | 0.71 | -0.44 | 0.62 | 0.39 | Upgrade
|
Filing Date Shares Outstanding | 67.27 | 67.27 | 55.23 | 37.59 | 29.8 | 26.09 | Upgrade
|
Total Common Shares Outstanding | 67.27 | 65.93 | 55.14 | 37.24 | 29.72 | 25.55 | Upgrade
|
Working Capital | 113.15 | 109.39 | 38.62 | 56.17 | 28.11 | 14.75 | Upgrade
|
Book Value Per Share | 1.76 | 1.74 | 0.80 | -0.06 | 1.20 | 0.90 | Upgrade
|
Tangible Book Value | 114.61 | 110.85 | 39.68 | -7.59 | 29.68 | 16.22 | Upgrade
|
Tangible Book Value Per Share | 1.70 | 1.68 | 0.72 | -0.20 | 1.00 | 0.63 | Upgrade
|
Machinery | 2.33 | 2.31 | 2.21 | 2.08 | 1.95 | 1.4 | Upgrade
|
Construction In Progress | 0.01 | 0.03 | - | 0.02 | 0.19 | 0.07 | Upgrade
|
Leasehold Improvements | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.81 | Upgrade
|
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.